178 related articles for article (PubMed ID: 22378655)
1. FLT3 mutation status is a predictor of early death in pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group.
Kutny MA; Moser BK; Laumann K; Feusner JH; Gamis A; Gregory J; Larson RA; Powell BL; Stock W; Willman CL; Woods WG; Meshinchi S
Pediatr Blood Cancer; 2012 Oct; 59(4):662-7. PubMed ID: 22378655
[TBL] [Abstract][Full Text] [Related]
2. Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study.
Lucena-Araujo AR; Kim HT; Jacomo RH; Melo RA; Bittencourt R; Pasquini R; Pagnano K; Fagundes EM; Chauffaille Mde L; Chiattone CS; Lima AS; Ruiz-Argüelles G; Undurraga MS; Martinez L; Kwaan HC; Gallagher R; Niemeyer CM; Schrier SL; Tallman MS; Grimwade D; Ganser A; Berliner N; Ribeiro RC; Lo-Coco F; Löwenberg B; Sanz MA; Rego EM
Ann Hematol; 2014 Dec; 93(12):2001-10. PubMed ID: 24981688
[TBL] [Abstract][Full Text] [Related]
3. Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia.
Gale RE; Hills R; Pizzey AR; Kottaridis PD; Swirsky D; Gilkes AF; Nugent E; Mills KI; Wheatley K; Solomon E; Burnett AK; Linch DC; Grimwade D;
Blood; 2005 Dec; 106(12):3768-76. PubMed ID: 16105978
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide in front-line therapy of acute promyelocytic leukemia (C9710): prognostic significance of FLT3 mutations and complex karyotype.
Poiré X; Moser BK; Gallagher RE; Laumann K; Bloomfield CD; Powell BL; Koval G; Gulati K; Holowka N; Larson RA; Tallman MS; Appelbaum FR; Sher D; Willman C; Paietta E; Stock W
Leuk Lymphoma; 2014 Jul; 55(7):1523-32. PubMed ID: 24160850
[TBL] [Abstract][Full Text] [Related]
5. [Prevalence and clinical significance of FLT3 mutations in acute promyelocytic leukemia].
Xue MX; Qiu HY; Feng YF; Zhu ZL; Chang WR; Liang JY; Chen SN; Cen JN; Xue YQ; Liu YJ; Sun AN; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):757-61. PubMed ID: 19176014
[TBL] [Abstract][Full Text] [Related]
6. Inferior prognostic outcome in acute promyelocytic leukemia with alterations of FLT3 gene.
Yoo SJ; Park CJ; Jang S; Seo EJ; Lee KH; Chi HS
Leuk Lymphoma; 2006 Sep; 47(9):1788-93. PubMed ID: 17064989
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Significance of bcr-1 and bcr-3 Isoforms of PML-RARA and FLT3-ITD in Patients With Acute Promyelocytic Leukemia.
Rasekh EO; Elsayed GM; Madney Y; El Gammal MM
Clin Lymphoma Myeloma Leuk; 2020 Mar; 20(3):156-167. PubMed ID: 32033928
[TBL] [Abstract][Full Text] [Related]
8. 'FLT3-ITD Mutation Does Not Influence Survival Outcome in Adult Acute Promyelocytic Leukemia Patients Treated With ATO and ATRA-Based Therapeutic Regimen: Experience From a North Indian Tertiary Care Centre'.
Deka RR; Naseem S; Bhatia P; Binota J; Sonam P; Rana P; Malhotra P; Varma N
Clin Lymphoma Myeloma Leuk; 2022 Jun; 22(6):416-423. PubMed ID: 34987015
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations in acute promyelocytic leukemia: a systematic review.
Beitinjaneh A; Jang S; Roukoz H; Majhail NS
Leuk Res; 2010 Jul; 34(7):831-6. PubMed ID: 20096459
[TBL] [Abstract][Full Text] [Related]
10. [FLT3-ITD Mutation in Newly Diagnosed Patients with Acute Promyelocytic Leukemia].
Gong BF; Wang Y; Lin D; Wei H; Li W; Zhou CL; Liu BC; Liu KQ; Zhang GJ; Liu YT; Li Y; Wei SN; Gong XY; Zhao XL; Qiu SW; Gu RX; Mi YC; Wang JX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1615-1621. PubMed ID: 28024465
[TBL] [Abstract][Full Text] [Related]
11. Treatment-influenced associations of PML-RARα mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia.
Gallagher RE; Moser BK; Racevskis J; Poiré X; Bloomfield CD; Carroll AJ; Ketterling RP; Roulston D; Schachter-Tokarz E; Zhou DC; Chen IM; Harvey R; Koval G; Sher DA; Feusner JH; Tallman MS; Larson RA; Powell BL; Appelbaum FR; Paietta E; Willman CL; Stock W
Blood; 2012 Sep; 120(10):2098-108. PubMed ID: 22734072
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic and FMS-like tyrosine kinase 3 mutation analyses in acute promyelocytic leukemia patients.
Yaghmaie M; Alimoghaddam K; Mozdarani H; Ghavamzadeh A; Hajhashemi M; Aznab M; Ghaffari SH
Iran Biomed J; 2012; 16(1):10-7. PubMed ID: 22562027
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group.
Callens C; Chevret S; Cayuela JM; Cassinat B; Raffoux E; de Botton S; Thomas X; Guerci A; Fegueux N; Pigneux A; Stoppa AM; Lamy T; Rigal-Huguet F; Vekhoff A; Meyer-Monard S; Ferrand A; Sanz M; Chomienne C; Fenaux P; Dombret H;
Leukemia; 2005 Jul; 19(7):1153-60. PubMed ID: 15889156
[TBL] [Abstract][Full Text] [Related]
14. Molecular characteristics and chromatin texture features in acute promyelocytic leukemia.
De Mello MR; Albuquerque DM; Pereira-Cunha FG; Albanez KB; Pagnano KB; Costa FF; Metze K; Lorand-Metze I
Diagn Pathol; 2012 Jun; 7():75. PubMed ID: 22742960
[TBL] [Abstract][Full Text] [Related]
15. FLT3 internal tandem duplication does not impact prognosis after haploidentical allogeneic hematopoietic stem cell transplantation in AML patients.
Zhang YY; Mo XD; Zhang XH; Xu LP; Wang Y; Yan CH; Chen H; Chen YH; Han W; Wang FR; Wang JZ; Sun YQ; Liu KY; Huang XJ
Bone Marrow Transplant; 2019 Sep; 54(9):1462-1470. PubMed ID: 30710101
[TBL] [Abstract][Full Text] [Related]
16. Internal tandem duplication and Asp835 mutations of the FMS-like tyrosine kinase 3 (FLT3) gene in acute promyelocytic leukemia.
Shih LY; Kuo MC; Liang DC; Huang CF; Lin TL; Wu JH; Wang PN; Dunn P; Lai CL
Cancer; 2003 Sep; 98(6):1206-16. PubMed ID: 12973844
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of FLT3 mutations in pediatric AML.
Meshinchi S; Alonzo TA; Stirewalt DL; Zwaan M; Zimmerman M; Reinhardt D; Kaspers GJ; Heerema NA; Gerbing R; Lange BJ; Radich JP
Blood; 2006 Dec; 108(12):3654-61. PubMed ID: 16912228
[TBL] [Abstract][Full Text] [Related]
18. FLT3 internal tandem duplication in childhood acute myeloid leukaemia: association with hyperleucocytosis in acute promyelocytic leukaemia.
Arrigoni P; Beretta C; Silvestri D; Rossi V; Rizzari C; Valsecchi MG; Cazzaniga G; Biondi A
Br J Haematol; 2003 Jan; 120(1):89-92. PubMed ID: 12492581
[TBL] [Abstract][Full Text] [Related]
19. PML-RARα kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy.
Cicconi L; Divona M; Ciardi C; Ottone T; Ferrantini A; Lavorgna S; Alfonso V; Paoloni F; Piciocchi A; Avvisati G; Ferrara F; Di Bona E; Albano F; Breccia M; Cerqui E; Sborgia M; Kropp MG; Santoro A; Levis A; Sica S; Amadori S; Voso MT; Mandelli F; Lo-Coco F
Leukemia; 2016 Oct; 30(10):1987-1992. PubMed ID: 27133819
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group.
Ho PA; Zeng R; Alonzo TA; Gerbing RB; Miller KL; Pollard JA; Stirewalt DL; Heerema NA; Raimondi SC; Hirsch B; Franklin JL; Lange B; Meshinchi S
Blood; 2010 Aug; 116(5):702-10. PubMed ID: 20413658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
